APT Medical Inc (688617) - Total Assets
Based on the latest financial reports, APT Medical Inc (688617) holds total assets worth CN¥3.46 Billion CNY (≈ $506.42 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See 688617 net assets for net asset value and shareholders' equity analysis.
APT Medical Inc - Total Assets Trend (2017–2024)
This chart illustrates how APT Medical Inc's total assets have evolved over time, based on quarterly financial data.
APT Medical Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
APT Medical Inc's total assets of CN¥3.46 Billion consist of 54.2% current assets and 45.8% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 36.3% |
| Accounts Receivable | CN¥89.81 Million | 3.0% |
| Inventory | CN¥399.32 Million | 13.4% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥402.00 Million | 13.5% |
| Goodwill | CN¥48.13 Million | 1.6% |
Asset Composition Trend (2017–2024)
This chart illustrates how APT Medical Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see APT Medical Inc market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: APT Medical Inc's current assets represent 54.2% of total assets in 2024, a decrease from 63.2% in 2017.
- Cash Position: Cash and equivalents constituted 36.3% of total assets in 2024, up from 31.4% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 14.0% of total assets, an increase from 0.0% in 2017.
- Asset Diversification: The largest asset category is intangible assets at 13.5% of total assets.
APT Medical Inc Competitors by Total Assets
Key competitors of APT Medical Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.54 Billion |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
Shanghai Kinetic Medical Co
SHE:300326
|
China | CN¥3.38 Billion |
|
Eurobio Scientific SA
PA:ALERS
|
France | €259.11 Million |
|
EBR Systems Inc
AU:EBR
|
Australia | AU$97.29 Million |
|
PULSION Medical Systems SE
MU:PUS
|
Germany | €35.15 Million |
|
Aroa Biosurgery Ltd
AU:ARX
|
Australia | AU$95.27 Million |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033
|
China | CN¥805.10 Million |
APT Medical Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.38 | 4.23 | 3.20 |
| Quick Ratio | 4.11 | 3.05 | 1.87 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥1.61 Billion | CN¥1.12 Billion | CN¥240.85 Million |
APT Medical Inc - Advanced Valuation Insights
This section examines the relationship between APT Medical Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 10.97 |
| Latest Market Cap to Assets Ratio | 1.62 |
| Asset Growth Rate (YoY) | 15.8% |
| Total Assets | CN¥2.98 Billion |
| Market Capitalization | $4.84 Billion USD |
Valuation Analysis
Above Book Valuation: The market values APT Medical Inc's assets above their book value (1.62x), reflecting positive investor sentiment about the company's future prospects.
Rapid Asset Growth: APT Medical Inc's assets grew by 15.8% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for APT Medical Inc (2017–2024)
The table below shows the annual total assets of APT Medical Inc from 2017 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥2.98 Billion ≈ $436.17 Million |
+15.85% |
| 2023-12-31 | CN¥2.57 Billion ≈ $376.51 Million |
+15.59% |
| 2022-12-31 | CN¥2.23 Billion ≈ $325.73 Million |
+10.58% |
| 2021-12-31 | CN¥2.01 Billion ≈ $294.58 Million |
+241.95% |
| 2020-12-31 | CN¥588.71 Million ≈ $86.15 Million |
+4.93% |
| 2019-12-31 | CN¥561.03 Million ≈ $82.10 Million |
+72.19% |
| 2018-12-31 | CN¥325.82 Million ≈ $47.68 Million |
+28.91% |
| 2017-12-31 | CN¥252.74 Million ≈ $36.98 Million |
-- |
About APT Medical Inc
APT Medical Inc. engages in the research and development, production, and sale of cardiovascular interventional medical devices in China. The company offers electrophysiology products, such as mapping, ablation, and navigated catheter, as well as steerable, and transseptal needle and sheet; and interventional cardiology and peripheral products, including access, diagnostic, therapeutic, and acces… Read more